SHANGHAI, China, March 26 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China's leading provider of pharmaceutical R&D outsourcing services announced today that it has purchased and successfully brought online a Berger Supercritical Fluid Chromatography (SFC) MultiGram(R)III preparative system.
(Logo: http://www.prnasia.com/sa/200611271812.jpg )
Supercritical Fluid Chromatography (SFC) is a relatively recent chromatographic technique offering superior speed and efficiency for chiral separation and compound purification. Preparative SFC uses carbon dioxide as mobile phase instead of organic solvents in HPLC, so it is a green technology for rapid access to enantiomers in pharmaceutical industry.
"WuXi PharmaTech is the first company in China to install a MultiGram(R)III and continues to be a leader in the use of the most modern technology," noted Mr. Eric Lim, General Manager of Lab Business, Mettler-Toledo China.
As the company's third SFC, this latest addition will play an important role in the research and separation of chiral drugs and intermediates. This preparative system expands WuXi PharmaTech's chiral separation capability from multi-grams to multi-kilograms. It also greatly expands the capability of WuXi PharmaTech's Kilogram-scale laboratories, and enhancing the company's analytical efficiency.
"WuXi PharmaTech is honored to be once again setting the standard for research efficiency and quality in China," commented Dr. Ning Zhao, Vice President of Analytical Services, WuXi PharmaTech. "Our goal is simple: to provide the best and most efficient service possible. Utilizing a MultiGram(R)III SFC system is a logical next step", continued Dr. Zhao.
About WuXi PharmaTech Co., Ltd.
Founded in 2001, Shanghai-based WuXi PharmaTech is China's leading drug R&D service company. As a research-driven and customer-focused company, WuXi PharmaTech offers global pharmaceutical and biopharmaceutical companies a diverse, value-added, and fully integrated portfolio of outsourcing services ranging from discovery chemistry, and process chemistry to service biology, bioanalytical chemistry, and large scale GMP manufacturing. WuXi PharmaTech assists its global partners in shortening the cycle and lowering the cost of drug discovery and development by providing cost-effective and efficient outsourcing solutions that save our clients both time and money. Currently, our client list consists of 19 of the top 20 pharmaceutical, and 8 of the top 10 biopharmaceutical companies. For more information, please visit http://www.pharmatechs.com .
